EMBC Stock Analysis: Buy, Sell, or Hold?
EMBC - Embecta Corp. Common Stock
$3.08
-0.13 (-4.05%)
▼
5d:
-9.68%
30d:
-9.68%
90d:
-65.04%
HOLD
LOW Confidence
Analysis Updated: Jun 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When EMBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EMBC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: EMBC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.92
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$4.92
37.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EMBC is currently trading at $3.08, which is considered fair relative to its 30-day fair value range of $2.41 to $4.65. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.8) compared to its historical average (3.3). Remarkably, the market is currently pricing in an annual earnings decline of 18.3% over the next few years. This pessimistic expectation contrasts with the company's recent 82.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EMBC is in a strong downtrend. The price is currently testing key support at $3.02. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: EMBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+29.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EMBC is in a strong downtrend. The price is currently testing key support at $3.02. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: EMBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+29.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.41 -
$4.65
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 29.9% below Wall St target ($4.00)
- CAUTION: Recommendation downgraded due to -9.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$2.41 -
$4.65
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.02
Resistance Level
$3.54
Current Trend
Strong Downtrend
Technical data as of
Jun 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.77
Wall Street Target
$4.00
(+29.9%)
Revenue Growth (YoY)
-14.4%
Earnings Growth (YoY)
82.7%
Profit Margin
10.7%
Valuation Discount vs History
-18.3% cheaper
PE vs Historical
1.8 vs 3.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.3%
(market-implied from PE analysis)
1-Year Target
$2.77
(-10%)
2-Year Target
$2.49
(-19%)
3-Year Target
$2.25
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$4.19
(+36%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 9.3%)
$49.75
(+1515%)
Base:
(SPY PE: 1.8, Growth: 9.3%)
$4.02
(+30%)
Bear:
(PE: 1.5, Growth: 9.3%)
$3.41
(+11%)
📈
Valuation based on Current Earnings
Trailing PE: 1.72 | Current EPS (TTM): $1.89
Bull Case
$3.30
(+7%)
Analyst growth -7.9%, PE expands to 1.9
Base Case
$3.00
(-3%)
Market implied -7.9%, PE stable at 1.7
Bear Case
$2.22
(-28%)
Severe decline -20.0%, PE contracts to 1.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.8 to 3.3
Stabilization Target:
$5.74
(+86.4%)
PE Expansion Potential:
+86.4%
Share & Embed Analysis
Last updated: June 12, 2026 1:06 AM ET
Data refreshes hourly during market hours. Next update: 2:06 AM
Data refreshes hourly during market hours. Next update: 2:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EMBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$89 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$352 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 53 HOLD |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$10 | 64 BUY |
